Why the study?
COVID-19 can affect cardiovascular function, but the effect of prior COVID-19 infection on cardiovascular phenotype at rest and in response to exercise in middle-aged and older individuals required assessment.
Does prior COVID-19 infection reduce cardiovascular function and exercise tolerance in healthy middle-age and older individuals?
Case-Control (n=124)
No
Does prior COVID-19 infection reduce cardiovascular function and exercise tolerance in healthy middle-age and older individuals?
Prior COVID-19 infection in healthy middle-aged and older individuals is associated with reduced exercise tolerance and blunted cardiac function response to exercise, despite normal resting hemodynamics.
Answers are grounded in this paper and cite their sources.
Prior COVID-19 was associated with reduced exercise tolerance and peak cardiac output; leaves open whether routine screening or monitoring is warranted.
:Aims Coronavirus disease (COVID-19) can affect cardiovascular function in health and disease. The present study assessed the effect of prior COVID-19 infection on cardiovascular phenotype at rest and in response to exercise in middle age and older individuals.Methods This case-control, single-centre study recruited 124 participants: 84 with a history of COVID-19 (59.9 ± 7.41 years, 54.8% female) and 40 participants without history of COVID-19 infection (62.8 ± 7.14 years, 62.5% female). All participants underwent non-invasive assessment of arterial function using pulse wave velocity (PWV), augmentation index (Alx) and hemodynamic function (i.e., cardiac index (CI), stroke volume index (SVI), heart rate (HR), mean arterial blood pressure (MAP)) at rest. Cardiopulmonary exercise stress testing with simultaneous gas exchange and hemodynamic (bioreactance) measurements was also performed.Results There were no differences between COVID-19 and non-COVID-19 groups in PWV (COVID-19: 7.52 ± 1.66 m/s, non-COVID-19: 7.32 ± 1.79 m/s, p = 0.440); Alx (COVID-19: 29.2 ± 9.12%, non-COVID-19: 29.2 ± 8.44%, p = 0.980); CI (COVID-19: 2.85 ± 0.39 L/min/m2, non-COVID-19: 2.79 ± 0.37 L/min/m2, p = 0.407); SVI (COVID-19: 46.5 ± 7.54 mL/m2, non-COVID-19: 47.0 ± 7.59 mL/m2, p = 0.776), HR (COVID-19: 62.3 ± 10.6 beats/min, Non-COVID-19: 60.2 ± 8.52 beats/min, p = 0.263), or MAP (COVID-19: 98.1 ± 11.2 mmHg, non-COVID-19: 96.6 ± 9.46 mmHg, p = 0.464). COVID-19 participants however demonstrated lower O2 consumption at anaerobic threshold (15.5 ± 4.25 vs 16.8 ± 4.51 mL/kg/m2, p = 0.034), peak cardiac index (10.4 ± 2.3 vs 11.3 ± 2.5 L/min/m2, p = 0.040) and peak stroke volume index (82.1 ± 25.3 vs 98.6 ± 37.6 mL/m2, p = 0.028).Conclusion Healthy middle-age and older individuals with history COVID-19 infection demonstrate reduced exercise tolerance and cardiac function response to exercise.
No takes yet. Share an insight, caveat, or question.
Russell et al. (2025) conducted a case-control in Prior COVID-19 infection (n=124). Prior COVID-19 infection vs. No history of COVID-19 infection was evaluated on O2 consumption at anaerobic threshold (mL/kg/m2) (p=0.034).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: